QuidelOrtho to Report Second Quarter 2025 Financial Results
QuidelOrtho (NASDAQ: QDEL), a global provider of in vitro diagnostic technologies, has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, after market close.
The company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results. Investors can access the webcast through QuidelOrtho's investor relations website, or join via phone using specific dial-in numbers. Presentation materials will be available on the company's website concurrent with the call.
QuidelOrtho (NASDAQ: QDEL), fornitore globale di tecnologie diagnostiche in vitro, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per martedì 5 agosto 2025, dopo la chiusura dei mercati.
L'azienda terrà una conference call alle 14:00 PT / 17:00 ET per discutere i risultati. Gli investitori potranno seguire la diretta web tramite il sito dedicato agli investitori di QuidelOrtho o partecipare telefonicamente utilizzando i numeri di accesso specifici. I materiali della presentazione saranno disponibili sul sito aziendale contemporaneamente alla chiamata.
QuidelOrtho (NASDAQ: QDEL), proveedor global de tecnologías de diagnóstico in vitro, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el martes 5 de agosto de 2025, después del cierre del mercado.
La compañía realizará una conferencia telefónica a las 2:00 p.m. PT / 5:00 p.m. ET para analizar los resultados. Los inversores podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de QuidelOrtho o unirse por teléfono usando números de marcación específicos. Los materiales de la presentación estarán disponibles en el sitio web de la empresa simultáneamente con la llamada.
QuidelOrtho (NASDAQ: QDEL)는 체외 진단 기술의 글로벌 제공업체로서 2025년 2분기 재무 실적 발표를 2025년 8월 5일 화요일 장 마감 후에 예정하고 있습니다.
회사는 오후 2:00 PT / 5:00 ET에 컨퍼런스 콜을 개최하여 실적을 논의할 예정입니다. 투자자들은 QuidelOrtho 투자자 관계 웹사이트를 통해 웹캐스트에 접속하거나 특정 전화 접속 번호를 사용해 전화로 참여할 수 있습니다. 발표 자료는 콜과 동시에 회사 웹사이트에 제공될 예정입니다.
QuidelOrtho (NASDAQ : QDEL), fournisseur mondial de technologies de diagnostic in vitro, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le mardi 5 août 2025, après la clôture du marché.
La société organisera une conférence téléphonique à 14h00 PT / 17h00 ET pour discuter des résultats. Les investisseurs pourront accéder au webinaire via le site des relations investisseurs de QuidelOrtho ou participer par téléphone en utilisant des numéros d'appel spécifiques. Les documents de présentation seront disponibles sur le site de l'entreprise en même temps que l'appel.
QuidelOrtho (NASDAQ: QDEL), ein globaler Anbieter von In-vitro-Diagnostiktechnologien, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Dienstag, den 5. August 2025, nach Börsenschluss geplant.
Das Unternehmen wird um 14:00 Uhr PT / 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können den Webcast über die Investor-Relations-Website von QuidelOrtho verfolgen oder per Telefon über spezielle Einwahlnummern teilnehmen. Präsentationsmaterialien werden zeitgleich mit dem Anruf auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at https://ir.quidelortho.com. Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) and entering Conference ID number 689337.
A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic.
Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@quidelortho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@quidelortho.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-report-second-quarter-2025-financial-results-302511072.html
SOURCE QuidelOrtho Corporation
FAQ
When will QuidelOrtho (QDEL) report Q2 2025 earnings?
How can investors access QuidelOrtho's Q2 2025 earnings call?
What time is QuidelOrtho's Q2 2025 earnings call?
Where can investors find QuidelOrtho's Q2 2025 earnings presentation materials?
